Analyst Information for Anika Therapeutics Inc.

$ 42.57   0.16 (+0.38%) Volume: 146.76k 4:00 PM EST Feb 19, 2020
After Hours:  $ 42.57 0.00 (0.00%) Volume: 636 4:00 PM EST Feb 19, 2020
Consensus Rating Average
Consensus Rating for ANIK is MODERATE BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 1.80
Previous Average Recommendation 2.20
Change in Average Recommendation -0.40
Number of Analysts Reporting 5
Strong Buy
1.0
Current: 1.80
Previous: 2.20
Change: -0.40
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations 374
Rank Recommendation relative to companies in its industry 314
Ranked 314 in Industry
1374 MED-BIOMED/GENE
Analyst Recommendations
Analysts recommending Strong Buy 4
Analysts recommending Moderate Buy 0
Analysts recommending Hold 0
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 1
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 3 3 3
Moderate Buy 0 0 0 0
Hold 0 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.80 2.20 2.20 2.20

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.